The panel endorsed a shot from biotechnology company Moderna on Thursday, making it all but certain the Food and Drug Administration will authorize a second vaccine in the same week doses of the Pfizer-BioNTech vaccine started to be given in a quest to slow a pandemic that has killed more than 310,000 people in the United States. |
No comments:
Post a Comment